Opioid Package Prototype (OPP) (NCT04598074)
The Feasibility and Effectiveness of an Opioid Package Prototype (OPP) to Impact Opioid Prescribing, Dispensing, and Patient Use Outcomes
🩺 Plain-English Summary (8th-Grade Level)
The overall objective of this clinical trial is to identify the impact of selected package features, known as the Opioid Package Prototype (OPP), on the safe and effective use of opioids. Our specific aims are: (Aim 1) to evaluate the effectiveness of OPP on prescribing, dispensing, and patient use of oxycodone among orthopaedic surgery patients receiving post-operative outpatient oxycodone for post-surgical pain management, and (Aim 2) to determine the feasibility of OPP for orthopaedic surgery prescribers, pharmacists, and orthopaedic surgery patients. Such data can be used to further optimize packaging and labeling design, help patients and caregivers utilize their medication and packaging correctly, and improve prescribing and dispensing habits. The central hypothesis is that the OPP will be more effective than the amber vial in efforts to reduce oxycodone prescribing among patients over 18 receiving short-term management of post orthopedic surgery pain.
Who can join: Review the eligibility criteria below.
Location: UConn Health — Farmington, Connecticut
Age range: 18 Years
🧪 Interventions in This Study
- Opioid Package Prototype (OPP) (OTHER)
- Usual Care (standard amber vial) (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UConn Health — Farmington, Connecticut
📞 Contact the Study Coordinator
Phone: (860) 486-6026
Email: nathaniel.rickles@uconn.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Use
- Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse — Raleigh, North Carolina
- Treating Polysubstance Use Using a Novel Digital Technology — Baltimore, Maryland
- Opioid Analgesic Reduction Study — Chicago, Illinois
- Patient Utilization of Opioid Destruction Bags in the Post-op Period — Omaha, Nebraska
- Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure — Chicago, Illinois
- SLeep and OPioid UsE in Patients Undergoing Total Knee Arthroplasty — La Jolla, California
Explore by condition: All Opioid Use clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.